|
Catalog Number SEPX-8-6-40-135 |
Device Problems
Difficult to Remove (1528); Activation, Positioning or Separation Problem (2906)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 11/03/2021 |
Event Type
malfunction
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Physician attempted to use a protégé rx self-expanding stent during treatment of a calcified lesion in the patient's right proximal and distal common carotid artery.Slight vessel tortuosity and moderate calcification are reported.Lesion exhibited 50% stenosis.There was no damage noted to packaging (i.E.Shelf carton, hoop/tray).There were no issues noted when removing the device from the hoop/tray.The device was prepped per ifu with no issues identified.The thumbscrew/lock-pin was checked for securement prior to procedure.Pre-dilation was not performed.The device was not passed through a previously deployed stent.No resistance was noted during advancement. deployment issues are reported.It is reported the stent was unable to be deployed. the device was safely removed from the patient.The stent struts were expose/visible on removal.A different brand stent was used to complete the procedure.No patient injury reported.
|
|
Manufacturer Narrative
|
Additional information: there was no vessel damage noted.Resistance was noted during device removal that device removal withdrawal of the stent was in the guiding catheter and then removed from the body.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Manufacturer Narrative
|
Product analysis: the device returned coiled in its product tray inside its shelf carton.Lot number on tray and carton label: b186234.Device was decontaminated with cidex opa solution soak and tergazyme soak.The device was returned with the touhy-borst tight and with a kink approximately 17.5cm from the tip.The device was returned with the stent fully enclosed.The stent was confirmed as 40mm, and there is biologics present in the device.The device could not be flushed, possibly due to the kink and the biologics in the shaft.A 0.014¿ guidewire could only be partially loaded due to the kink, and the device was loaded into a deployment fixture.The stent could not be deployed with a maximum peak force of 5.80lbs.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|